[1] CDC, "Current Trends Update on Acquired Immune Deficiency
Syndrome (AIDS)” 131, 1982, 507-508, 513-514. Available at:
http://www.who.int/hiv/strategic/cdc_1982%20_aids_def.pdf Accessed
at: 8/3/09.
[2] E. Bailes, R. Chaudhuri, M. Santiago, F. Bibollet-Ruche, B. Hahn, and
P. Sharp, "The evolution of Primate Lentiviruses and the Origins of
AIDS” in The Molecular Epidemiology of Human Viruses. Sweden:
Kluwer Academic Publishers, 2002.
[3] UNAIDS, "Status of the global HIV epidemic,” in 2008 Report on the
Global AIDS Epidemic, 2008, ch 2. Available at: http://www.unaids.org/
en/media/unaids/contentassets/dataimport/pub/globalreport/2008/jc1510
_2008globalreport_en.pdf. (Accessed:02/09/2014).
[4] CDC "1993 Revised Classification System for HIV Infection and
Expanded Surveillance Case Definition for AIDS Among Adolescents
and Adults”. Available at: http://www.cdc.gov/mmwr/preview/
mmwrhtml/00018871.htm. (Accessed : 02/09/2014).
[5] L. Gordis L, Epidemiology. Baltimore: Saunders Elsevier, 2009
[6] J. Giesecke, Modern Infectious Disease Epidemiology. London, Arnold,
2012, ch18.
[7] V. Harden V, 2Koch’s Postulates and the Etiology of AIDS: An
Historical perspective,” History and Phiolosophy of the Life Sciences,
14, 1992, 249-269.
[8] D. Smith, J. Neal, and Holmberg, "Unexplained opportunistic
infections and CD4+ T-lymphocytopenia without HIV infection. An
investigation of cases in the United States,” The Centers for Disease
Control Idiopathic CD4+ T-lymphocytopenia Task Force’ The New
England Journal of medicine, 328, 1993, 373-9
[9] Y. Cao, L. Qin, L. Zhang, J. Safrit, and D. Ho, "Virologic and
immunologic characterization of long-term survivors of human
immunodeficiency virus type 1 infection,” New England Journal of
Medicine, 332, 1995, 201-8.
[10] T. Greenough, D. Brettler, F. Kirchhoff, L. Alexander, R. Desrosiers, S.
Somasundaran, M. Luzuriag and J. Sullivan, "Long-term non
progressive infection with human immunodeficiency virus type 1 in a
hemophilia cohort,” J Infect Dis, 180, 1999, 1790-802.
[11] G. Pantaleo, S. Menzo, M. Vaccarezza, et al., "Studies in subjects with
long-term progressive human immunodeficiency virus infection,” New
England Journal of Medicine, 332, 1995, 209-16
[12] D. Gibellini, F. Vitone, P. Schiavone P, C. Ponti, M. La Placa, and M.
Re, "Quatitative Detection of human immunodeficiency virus type 1
(HIV-1) Proviral DNA in peripheral blood mononuclear cells by SYBR
green real-time PCR Technique,” Journal of Clinical Virology, 29, 2004,
282-9.
[13] S. Hammer, C. Crumpacker, R. D'Aquila, B. Jackson, J. Lathey, D.
Livnat, and P. Reicchelderfer, "Use of virologic assays for detection of
human immunodeficiency virus in clinical trials: recommendations of
the AIDS Clinical Trials Group Virology Committee,” Journal of
Clinical Microbiology, 31, 1993, 2557-64.
[14] S. Moroney, L. Heller, and R. Widen, "Evaluation of two TaqMan PCR
assays for the detection of HIV-1 proviral DNA in blood samples,”
Journal of Microbiological Methods, 65, 2006, 350-3.
[15] National Institute of AIDS and Infectious diseases -NIAID– National
Institute of Health, "The Evidence that HIV causes AIDS,” Available at:
http://www.niaid.nih.gov/topics/hivaids/understanding/howhivcausesaid
s/pages/hivcausesaids.aspx. (Accessed 02/09/2014)
[16] S. Vermund, D. Hoover, and K. Chen, "CD4+ counts in seronegative
homosexual men. The Multicenter AIDS Cohort Study,” The New
England Journal of Medicine, 328, 1993, 442
[17] J. Jackson, S. Kwok., J. Sninsky, J. Hopsicker, K. Sannerud K, F.
Rhame, K. Henry, M. Simpson, and H. Balfour, "Human
immunodeficiency virus type 1 detected in all seropositive symptomatic
and asymptomatic individuals,” Journal of Clinical Microbiology, 28,
1990, 16-9
[18] S. O’Brien, and J. Goedert, "HIV Causes AIDS: Koch’s postulates
fulfilled,” Current Opinion in Immunology, 8, 1996, 613-618.
[19] S. Weiss, J. Goedert, S. Gartner, M. Popovic, D. Waters, P. Markham, F.
Veronese, M. Gail, W. Barkle, J. Gibbons, et al., "Risk of human
immunodeficiency virus (HIV-1) infection among laboratory workers”
Science, 239, 1988, 68-71.
[20] M. Reitz, L. Hall, M. Robert-Guroff, J. Lautenberger, B. Hahn, J. Shaw,
L. Kong, S. Weiss, D. Waters, R. Gallo, and W. Blattner, "Viral
variability and serum antibody response in a laboratory worker infected
with HIV-1 (HTLV-IIIB),” AIDS Research and Human Retroviruses,
10, 1994, 1143-55
[21] CDC-Centers for disease control and Prevention "Surveillance of
Healthcare Personnel with HIV/AIDS as of December 2002,” 2002.
Available at: http://www.thebody.com/content/art17253.html. (Accessed
02/09/2014).
[22] CDC, "Surveillance of Occupationally Acquired HIV/AIDS in
Healthcare Personnel, as of December 2006,” 2006, Available at:
http://www.cdc.gov/HAI/organisms/hiv/Surveillance-Occupationally-
Acquired-HIV-AIDS.html. (Accessed 02/09/2014).
[23] H. Van den Berg, E. Gerritsen, M. Van Tol, L. Dooren, and J. Vossen,
"Ten years after acquiring g an HIV-1 infection: a study in a cohort of
eleven neonates infected by aliquots from a single plasma donation,”
ACTA Paediatrica, 83, 1994, 173-8
[24] S. O’ Neil S, F. Novembre, A. Hill, C. Suwyn, C. Hart, T. Evans-
Strickfaden, D. Anderson, J. deRosayro, J. Herndon, M. Saucier, and H.
McClure, "Progressive Infection in a subset of HIV-1-Positive
Chimpazees,” The Journal of Infectious Diseases, 182, 2000, 1051-62
[25] C. Locher, S. Barnett, B. Herndier, D. Blackbourn, G. Reyes-Teran, K.
Murthy, et al., "Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in
humans,” Archives of pathology & Laborotary Medicine, 122, 1998,
523-33.
[26] S. Joag, Z. Li, L. Foresman, E. Stephens, L. Zhao, I. Adany, et al.,
"Chimeric simian/human immunodeficiency virus that causes
progressive loss of CD4+ T cells and AIDS in pig-tailed macaques,”
Journal of Virology, 70, 1996, 3189-97.
[27] UNAIDS/WHO, "Epidemiological Fact Sheets on HIV/AIDS and
Sexually Transmitted Infections,” (2004).
[28] J. Mellors, A. Munoz, J. Giorgi, J. Margolick, C. Tassoni, P. Gupta, et
al., "Plasma viral load and CD4+ lymphocytes as prognostic markers of
HIV-1 infection,” Annals of Internal Medicine, 126, 1997, 946-54.
[29] K. Anastos, L. Kalish, N. Hessol, B. Weiser, S. Melnick, D. Burns, et
al., "The relative value of CD4 cell count and quantitative HIV-1 RNA
in predicting survival in HIV-1-infected women: results of the women's
interagency HIV study,” AIDS, 13, 1999, 1717-26.
[30] UNAIDS, "2008 Report on The Global AIDS Epidemic’ Annex 1: HIV
and AIDS Estimates and data 2007 and 2001,” 2008, Available at:
http://whqlibdoc.who.int/unaids/2008/9789291737116_eng_Annexes.pd
f. (Accessed 02/09/2014)
[31] E. Asamoah-Odei, J. Calleja, and J. Boerma, "HIV prevalence and
trends in sub-Saharan Africa: no decline and large subregional
differences,” The Lancet, 364, 2004, 35-40
[32] B. Weniger, K. Limpakarnjanarat, K. Ungchusak, S. Thanprasertsuk, K.
Choopanya, S. Vanichseni, et al., "The epidemiology of HIV infection
and AIDS in Thailand',” AIDS, 5 (suppl 2): 1991, S71-S85
[33] J. Cohen, "Could Drugs, Rather Than a Virus, Be the cause of AIDS?,”
Science, 266, 1994, 1648-1649. Available at:
http://www.sciencemag.org/site/feature/data/cohen/266-5191-1648a.pdf.
(Accessed 02/09/2014)
[34] T. Quinn, and J. Overbaugh, "HIV/AIDS in women: an expanding
epidemic” Science, 308, 2005, 1582-3.
[35] V. Simon, D. Ho, and Q. Karim, "HIV/AIDS epidemiology,
pathogenesis, prevention, and treatment,” The Lancet, 368, 2006, 489-
504
[36] R. Hogg, K. Heath, B. Yip, K. Craib, M. O’Shaughnessy, M. Schechter,
et al., "Improved survival among HIV-infected individuals following
initiation of antiretroviral therapy,” JAMA, 279, 1998, 450-454.
[37] F. Palella, K. Delaney, and A. Moorman, "Declining morbidity and
mortality among patients with advanced human immunodeficiency virus
infection. HIV Outpatient study Investigators,” The New England
Journal of Medicine, 338, 1998, 853-860.
[38] D. de Walque, "How does the impact of an HIV/AIDS information
campaign vary with educational attainment? Evidence from rural
Uganda,” Journal of Development Economics, Volume 84, 2007, 686-
714
[39] W. Punpanich, K. Ungchusak, and R. Detels, "Thailand’s response to
the HIV epidemic: yesterday, today and tomorrow,” AIDS Education
and Prevention, 16, 2004, 119-36.
[40] P. Gorbach, H. Sopheab, C. Chhorvann, R. Weiss, and M. Vun,
"Changing behaviors and patterns among Cambodian sex workers:
1997-2003,” Journal of Acquired Immune deficiency syndromes, 42,
2006, 242-7
[41] J. Carter, and V. Saunders, Virology Principles and Applications,
Chichester: John Wiley & Sons Ltd, 2007
[42] J. Levy, J. Shimabukuro, T. McHugh, C. Casavant, D. Stites, and L.
Oshiro, "AIDS-associated retroviruses (ARV) can productively infect
other cells besides human T-helper cells,” Virology, 147, 1985, 441
[43] M. Pope, S. Gezelter, N. Gallo, L. Hoffman, and R. Steinman, "Low
levels of HIV-1 infection in cutaneous dendritic cells promote extensive
viral replication upon binding to memory CD4_ T cells,” The Journal of
Experimental Medicine, 182, 1995, 2045-56
[44] P. Borrow, H. Lewicki, B. Hahn, G. Shaw, and M. Oldstone, "Virusspecific
CD8+ cytotoxic T-lymphocyte activity associated with control
of viremia in primary human immunodeficiency virus type 1 infection,”
Journal of Virology, 68, 1994, 6103–10
[45] R. Koup, J. Safrit, Y. Cao, C. Andrews, G. Mcleod, G. Borkowsky, C.
Farthing, and D. Ho D, "Temporal association of cellular immune
responses with the initial control of viremia in primary human
immunodeficiency virus type 1 syndrome,” Journal of Virology, 68,
1994, 4650–5
[46] CDC- Centers for Disease Control & Prevention, National Center for
HIV, STD, and TB Prevention, Divisions of HIV/AIDS Prevention,
"HIV Surveillance supported by Division of HIV/AIDS Prevention, 2004. Available at: http://www.cdc.gov/hiv/statistics/recommendations/
publications.html. . (Accessed 02/09/2014)
[47] J. Todd, J. Glynn, M. Marston, T. Lutalo, S. Biraro, W. Mwita et al.,
"Time from HIV seroconversion to death: a collaborative analysis of
eight studies in six low and middle-income countries before highly
active antiretroviral therapy,” AIDS, Suppl 6, 2007, S55-63.
[1] CDC, "Current Trends Update on Acquired Immune Deficiency
Syndrome (AIDS)” 131, 1982, 507-508, 513-514. Available at:
http://www.who.int/hiv/strategic/cdc_1982%20_aids_def.pdf Accessed
at: 8/3/09.
[2] E. Bailes, R. Chaudhuri, M. Santiago, F. Bibollet-Ruche, B. Hahn, and
P. Sharp, "The evolution of Primate Lentiviruses and the Origins of
AIDS” in The Molecular Epidemiology of Human Viruses. Sweden:
Kluwer Academic Publishers, 2002.
[3] UNAIDS, "Status of the global HIV epidemic,” in 2008 Report on the
Global AIDS Epidemic, 2008, ch 2. Available at: http://www.unaids.org/
en/media/unaids/contentassets/dataimport/pub/globalreport/2008/jc1510
_2008globalreport_en.pdf. (Accessed:02/09/2014).
[4] CDC "1993 Revised Classification System for HIV Infection and
Expanded Surveillance Case Definition for AIDS Among Adolescents
and Adults”. Available at: http://www.cdc.gov/mmwr/preview/
mmwrhtml/00018871.htm. (Accessed : 02/09/2014).
[5] L. Gordis L, Epidemiology. Baltimore: Saunders Elsevier, 2009
[6] J. Giesecke, Modern Infectious Disease Epidemiology. London, Arnold,
2012, ch18.
[7] V. Harden V, 2Koch’s Postulates and the Etiology of AIDS: An
Historical perspective,” History and Phiolosophy of the Life Sciences,
14, 1992, 249-269.
[8] D. Smith, J. Neal, and Holmberg, "Unexplained opportunistic
infections and CD4+ T-lymphocytopenia without HIV infection. An
investigation of cases in the United States,” The Centers for Disease
Control Idiopathic CD4+ T-lymphocytopenia Task Force’ The New
England Journal of medicine, 328, 1993, 373-9
[9] Y. Cao, L. Qin, L. Zhang, J. Safrit, and D. Ho, "Virologic and
immunologic characterization of long-term survivors of human
immunodeficiency virus type 1 infection,” New England Journal of
Medicine, 332, 1995, 201-8.
[10] T. Greenough, D. Brettler, F. Kirchhoff, L. Alexander, R. Desrosiers, S.
Somasundaran, M. Luzuriag and J. Sullivan, "Long-term non
progressive infection with human immunodeficiency virus type 1 in a
hemophilia cohort,” J Infect Dis, 180, 1999, 1790-802.
[11] G. Pantaleo, S. Menzo, M. Vaccarezza, et al., "Studies in subjects with
long-term progressive human immunodeficiency virus infection,” New
England Journal of Medicine, 332, 1995, 209-16
[12] D. Gibellini, F. Vitone, P. Schiavone P, C. Ponti, M. La Placa, and M.
Re, "Quatitative Detection of human immunodeficiency virus type 1
(HIV-1) Proviral DNA in peripheral blood mononuclear cells by SYBR
green real-time PCR Technique,” Journal of Clinical Virology, 29, 2004,
282-9.
[13] S. Hammer, C. Crumpacker, R. D'Aquila, B. Jackson, J. Lathey, D.
Livnat, and P. Reicchelderfer, "Use of virologic assays for detection of
human immunodeficiency virus in clinical trials: recommendations of
the AIDS Clinical Trials Group Virology Committee,” Journal of
Clinical Microbiology, 31, 1993, 2557-64.
[14] S. Moroney, L. Heller, and R. Widen, "Evaluation of two TaqMan PCR
assays for the detection of HIV-1 proviral DNA in blood samples,”
Journal of Microbiological Methods, 65, 2006, 350-3.
[15] National Institute of AIDS and Infectious diseases -NIAID– National
Institute of Health, "The Evidence that HIV causes AIDS,” Available at:
http://www.niaid.nih.gov/topics/hivaids/understanding/howhivcausesaid
s/pages/hivcausesaids.aspx. (Accessed 02/09/2014)
[16] S. Vermund, D. Hoover, and K. Chen, "CD4+ counts in seronegative
homosexual men. The Multicenter AIDS Cohort Study,” The New
England Journal of Medicine, 328, 1993, 442
[17] J. Jackson, S. Kwok., J. Sninsky, J. Hopsicker, K. Sannerud K, F.
Rhame, K. Henry, M. Simpson, and H. Balfour, "Human
immunodeficiency virus type 1 detected in all seropositive symptomatic
and asymptomatic individuals,” Journal of Clinical Microbiology, 28,
1990, 16-9
[18] S. O’Brien, and J. Goedert, "HIV Causes AIDS: Koch’s postulates
fulfilled,” Current Opinion in Immunology, 8, 1996, 613-618.
[19] S. Weiss, J. Goedert, S. Gartner, M. Popovic, D. Waters, P. Markham, F.
Veronese, M. Gail, W. Barkle, J. Gibbons, et al., "Risk of human
immunodeficiency virus (HIV-1) infection among laboratory workers”
Science, 239, 1988, 68-71.
[20] M. Reitz, L. Hall, M. Robert-Guroff, J. Lautenberger, B. Hahn, J. Shaw,
L. Kong, S. Weiss, D. Waters, R. Gallo, and W. Blattner, "Viral
variability and serum antibody response in a laboratory worker infected
with HIV-1 (HTLV-IIIB),” AIDS Research and Human Retroviruses,
10, 1994, 1143-55
[21] CDC-Centers for disease control and Prevention "Surveillance of
Healthcare Personnel with HIV/AIDS as of December 2002,” 2002.
Available at: http://www.thebody.com/content/art17253.html. (Accessed
02/09/2014).
[22] CDC, "Surveillance of Occupationally Acquired HIV/AIDS in
Healthcare Personnel, as of December 2006,” 2006, Available at:
http://www.cdc.gov/HAI/organisms/hiv/Surveillance-Occupationally-
Acquired-HIV-AIDS.html. (Accessed 02/09/2014).
[23] H. Van den Berg, E. Gerritsen, M. Van Tol, L. Dooren, and J. Vossen,
"Ten years after acquiring g an HIV-1 infection: a study in a cohort of
eleven neonates infected by aliquots from a single plasma donation,”
ACTA Paediatrica, 83, 1994, 173-8
[24] S. O’ Neil S, F. Novembre, A. Hill, C. Suwyn, C. Hart, T. Evans-
Strickfaden, D. Anderson, J. deRosayro, J. Herndon, M. Saucier, and H.
McClure, "Progressive Infection in a subset of HIV-1-Positive
Chimpazees,” The Journal of Infectious Diseases, 182, 2000, 1051-62
[25] C. Locher, S. Barnett, B. Herndier, D. Blackbourn, G. Reyes-Teran, K.
Murthy, et al., "Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in
humans,” Archives of pathology & Laborotary Medicine, 122, 1998,
523-33.
[26] S. Joag, Z. Li, L. Foresman, E. Stephens, L. Zhao, I. Adany, et al.,
"Chimeric simian/human immunodeficiency virus that causes
progressive loss of CD4+ T cells and AIDS in pig-tailed macaques,”
Journal of Virology, 70, 1996, 3189-97.
[27] UNAIDS/WHO, "Epidemiological Fact Sheets on HIV/AIDS and
Sexually Transmitted Infections,” (2004).
[28] J. Mellors, A. Munoz, J. Giorgi, J. Margolick, C. Tassoni, P. Gupta, et
al., "Plasma viral load and CD4+ lymphocytes as prognostic markers of
HIV-1 infection,” Annals of Internal Medicine, 126, 1997, 946-54.
[29] K. Anastos, L. Kalish, N. Hessol, B. Weiser, S. Melnick, D. Burns, et
al., "The relative value of CD4 cell count and quantitative HIV-1 RNA
in predicting survival in HIV-1-infected women: results of the women's
interagency HIV study,” AIDS, 13, 1999, 1717-26.
[30] UNAIDS, "2008 Report on The Global AIDS Epidemic’ Annex 1: HIV
and AIDS Estimates and data 2007 and 2001,” 2008, Available at:
http://whqlibdoc.who.int/unaids/2008/9789291737116_eng_Annexes.pd
f. (Accessed 02/09/2014)
[31] E. Asamoah-Odei, J. Calleja, and J. Boerma, "HIV prevalence and
trends in sub-Saharan Africa: no decline and large subregional
differences,” The Lancet, 364, 2004, 35-40
[32] B. Weniger, K. Limpakarnjanarat, K. Ungchusak, S. Thanprasertsuk, K.
Choopanya, S. Vanichseni, et al., "The epidemiology of HIV infection
and AIDS in Thailand',” AIDS, 5 (suppl 2): 1991, S71-S85
[33] J. Cohen, "Could Drugs, Rather Than a Virus, Be the cause of AIDS?,”
Science, 266, 1994, 1648-1649. Available at:
http://www.sciencemag.org/site/feature/data/cohen/266-5191-1648a.pdf.
(Accessed 02/09/2014)
[34] T. Quinn, and J. Overbaugh, "HIV/AIDS in women: an expanding
epidemic” Science, 308, 2005, 1582-3.
[35] V. Simon, D. Ho, and Q. Karim, "HIV/AIDS epidemiology,
pathogenesis, prevention, and treatment,” The Lancet, 368, 2006, 489-
504
[36] R. Hogg, K. Heath, B. Yip, K. Craib, M. O’Shaughnessy, M. Schechter,
et al., "Improved survival among HIV-infected individuals following
initiation of antiretroviral therapy,” JAMA, 279, 1998, 450-454.
[37] F. Palella, K. Delaney, and A. Moorman, "Declining morbidity and
mortality among patients with advanced human immunodeficiency virus
infection. HIV Outpatient study Investigators,” The New England
Journal of Medicine, 338, 1998, 853-860.
[38] D. de Walque, "How does the impact of an HIV/AIDS information
campaign vary with educational attainment? Evidence from rural
Uganda,” Journal of Development Economics, Volume 84, 2007, 686-
714
[39] W. Punpanich, K. Ungchusak, and R. Detels, "Thailand’s response to
the HIV epidemic: yesterday, today and tomorrow,” AIDS Education
and Prevention, 16, 2004, 119-36.
[40] P. Gorbach, H. Sopheab, C. Chhorvann, R. Weiss, and M. Vun,
"Changing behaviors and patterns among Cambodian sex workers:
1997-2003,” Journal of Acquired Immune deficiency syndromes, 42,
2006, 242-7
[41] J. Carter, and V. Saunders, Virology Principles and Applications,
Chichester: John Wiley & Sons Ltd, 2007
[42] J. Levy, J. Shimabukuro, T. McHugh, C. Casavant, D. Stites, and L.
Oshiro, "AIDS-associated retroviruses (ARV) can productively infect
other cells besides human T-helper cells,” Virology, 147, 1985, 441
[43] M. Pope, S. Gezelter, N. Gallo, L. Hoffman, and R. Steinman, "Low
levels of HIV-1 infection in cutaneous dendritic cells promote extensive
viral replication upon binding to memory CD4_ T cells,” The Journal of
Experimental Medicine, 182, 1995, 2045-56
[44] P. Borrow, H. Lewicki, B. Hahn, G. Shaw, and M. Oldstone, "Virusspecific
CD8+ cytotoxic T-lymphocyte activity associated with control
of viremia in primary human immunodeficiency virus type 1 infection,”
Journal of Virology, 68, 1994, 6103–10
[45] R. Koup, J. Safrit, Y. Cao, C. Andrews, G. Mcleod, G. Borkowsky, C.
Farthing, and D. Ho D, "Temporal association of cellular immune
responses with the initial control of viremia in primary human
immunodeficiency virus type 1 syndrome,” Journal of Virology, 68,
1994, 4650–5
[46] CDC- Centers for Disease Control & Prevention, National Center for
HIV, STD, and TB Prevention, Divisions of HIV/AIDS Prevention,
"HIV Surveillance supported by Division of HIV/AIDS Prevention, 2004. Available at: http://www.cdc.gov/hiv/statistics/recommendations/
publications.html. . (Accessed 02/09/2014)
[47] J. Todd, J. Glynn, M. Marston, T. Lutalo, S. Biraro, W. Mwita et al.,
"Time from HIV seroconversion to death: a collaborative analysis of
eight studies in six low and middle-income countries before highly
active antiretroviral therapy,” AIDS, Suppl 6, 2007, S55-63.
@article{"International Journal of Medical, Medicine and Health Sciences:52979", author = "A. Taqaddas", title = "Establishing Causal Relationship between HIV and AIDS", abstract = "This mini literature review discusses casual
relationships between HIV and AIDS in view of Koch’s postulates.
", keywords = "AIDS, Causal Relationship, HIV, Koch’s Postulates.", volume = "8", number = "9", pages = "554-5", }
